Trial NCT00572156

View at ClinicalTrials.gov 
Org. Study IDs: MS316
Secondary IDs: 2019-000843-29

Last trial update was posted on 2023-03-30

MeSH Interventions

Mecasermin

MeSH Conditions

Dwarfism

Other Conditions

Insulin-like Growth Factor-1 Deficiency

Stopping Reasons

The study was prematurely terminated due to strategic reasons.

Limitations And Caveats

The study was prematurely terminated once the last subject had completed three years of treatment (compared to the six years planned in protocol Amendment) for strategic reasons.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID